Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H16ClNO2S.ClH |
Molecular Weight | 358.283 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
InChI
InChIKey=XIHVAFJSGWDBGA-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.ClH/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;/h2-5,7,9,15H,6,8,10H2,1H3;1H/t15-;/m0./s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL KRKA (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-TAD (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-HCS (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL KRKA D.D. (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL KRKA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA PHARMA (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TAD (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-HCS (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL DURA (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL QUALIMED (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL QUALIMED (WITHDRAWN: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-DURA (WITHDRAWN: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL MYLAN (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA PHARMA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL KRKA D.D. (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-KRKA (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL KRKA D.D. (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL QUALIMED (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA GENERICS B.V. (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL DURA (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
NCI_THESAURUS |
C80483
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA PHARMA (AUTHORIZED: AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-HCS (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL MYLAN (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TAD (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL HCS (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL MYLAN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT002594
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
100000115888
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
120202-65-5
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
9798860
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
426O7XWS6Y
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
C96893
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
SUB30779
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY | |||
|
DTXSID40152734
Created by
admin on Fri Dec 15 17:57:17 UTC 2023 , Edited by admin on Fri Dec 15 17:57:17 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD